Oct 23, 2026 | Cancer, Claims, Employer costs, Health care costs, High-cost claims, Neonatal conditions, Stop-Loss
Stop-loss insurance protects self-funded employers from catastrophic claims, but multimillion-dollar claims from complex cancer care, premature births, and specialty treatments are hardening the market by driving higher premiums and tighter coverage terms. Recent...
Aug 28, 2026 | Breast cancer, Cancer, Claims, Colon Cancer, Heart disease, High-cost claims, MedBen WellLiving
Tokio Marine HCC’s 2026 Annual Market Report underscores two persistent drivers of high-cost claims. In 2025, cancers accounted for 35.2% of total costs and cardiovascular diseases another 12.7% — nearly 48% combined, far more than any other diagnostic categories....
Jul 17, 2026 | At-home colon cancer tests, Cancer, Colon Cancer, Colonoscopy, MedBen WellLiving, Wellness, Wellness screenings
The American Cancer Society has expanded colorectal cancer screening guidelines to include a new blood test and additional at-home stool options. The aim is greater accessibility, especially for those who might otherwise skip screening. However, the guidelines still...
Jul 7, 2026 | Cancer, Children, High-cost claims, Neonatal conditions, Stop-Loss
Tokio Marine HCC’s 2026 Annual Market Report shows children under age 10 now account for 39% of stop-loss claims exceeding $1 million — more than triple the share of any other 10-year age group. This concentrated risk creates new considerations for self-funded plans,...
Jun 17, 2026 | Cancer, Colon Cancer, Family doctors, Family health history, Preventive Care, Primary Care, Wellness
Knowing your family’s health history — and making sure your primary care physician knows it too — can make a real difference in catching serious conditions early. KFF Health News recently shared the story of a 33-year-old woman who discovered only after being...
May 27, 2026 | Cancer, Claims, Client Report, GLP-1s, Heart disease, Specialty Drugs, Stop-Loss, Trend
A new Sun Life analysis shows high-cost claims continue to strain employer health plans. The annual High-Cost Claims and Injectable Drug Trends report identifies comorbid conditions, long inpatient stays, and injectable specialty drugs as primary drivers of claims...